Flipboard: Your Social Magazine

https://www.nature.com/articles/s41591-019-0420-8

Apr 29, 2019

More stories from Immunotherapy for Cancer

Targeted Therapies and Immunotherapy Play Greater Role in Sarcomas
targetedonc.com - Neeta Somaiah, MD
Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signaling
nature.com - Ido Yofe, Tomer Landsberger, Adam Yalin, Isabelle Solomon, Cristobal Costoya, Dafne Franz Demane, Mansi Shah, Eyal David, Chamutal Borenstein, Oren Barboy, Ignacio Matos, Karl S. Peggs, Sergio A. Quezada , Ido Amit
How Tumor Cells Evade Immunotherapy and Cause Tumor Relapse
Genetic Engineering & Biotechnology News - Christina Jackson